At a glance
ClinicalIndex Comparison RecordN/ACompleted· 18 enrolled
Drug / intervention
Lehfilcon A multifocal contact lenses +2 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Clinical Evaluation of a Manufacturing Process for a Frequent Replacement Silicone Hydrogel Multifocal Contact Lens
In Brief
A clinical study evaluating Lehfilcon A multifocal contact lenses, Lotrafilcon B multifocal contact lenses, and 1 other intervention for Refractive Ametropia. Completed, enrolled 18 participants across 1 site.
Detailed Summary
The purpose of this clinical trial was to evaluate the clinical performance of a manufacturing process on a frequent replacement multifocal contact lens.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsRefractive Ametropia
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
202420252026
Enrollment StartMar 2023
First PostedMar 2023
Primary CompletionMar 2023
TodayJul 2026
First PostedMar 13, 2023
Enrollment StartMar 8, 2023
Primary CompletionMar 30, 2023
TodayJul 2, 2026
Enrollment to primary: 22 daysPosted 3.3 years ago
Interventions
Lehfilcon A multifocal contact lensesdevice
Investigational silicone hydrogel multifocal contact lenses
Lotrafilcon B multifocal contact lensesdevice
Commercially available silicone hydrogel multifocal contact lenses
Hydrogen peroxide-based cleaning and disinfection systemdevice
Commercially available cleaning and disinfection system for silicone hydrogel contact lenses